Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2026)

Inspire Medical Systems' Cost of Revenue history spans 10 years, with the latest figure at $27.7 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 9.89% to $27.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $130.2 million, a 0.97% increase, with the full-year FY2025 number at $133.2 million, up 8.33% from a year prior.
  • Cost of Revenue hit $27.7 million in Q1 2026 for Inspire Medical Systems, down from $36.1 million in the prior quarter.
  • Over the last five years, Cost of Revenue for INSP hit a ceiling of $36.1 million in Q4 2025 and a floor of $10.0 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $26.3 million across 5 years, with a median of $27.7 million in 2026.
  • Biggest five-year swings in Cost of Revenue: soared 129.43% in 2022 and later dropped 9.89% in 2026.
  • Tracing INSP's Cost of Revenue over 5 years: stood at $22.2 million in 2022, then grew by 26.64% to $28.1 million in 2023, then increased by 28.28% to $36.0 million in 2024, then increased by 0.23% to $36.1 million in 2025, then decreased by 23.29% to $27.7 million in 2026.
  • Business Quant data shows Cost of Revenue for INSP at $27.7 million in Q1 2026, $36.1 million in Q4 2025, and $31.8 million in Q3 2025.